CELL & GENE COLLABORATIVE BLOG
Anna Rose Welch
Click here to e-mail Anna Rose
Anna Rose Welch is the director of Cell & Gene Collaborative. In this role, she is forging close relationships with the leading voices and organizations in the cell and gene therapy manufacturing sphere. This includes establishing a peer group comprising Cell & Gene company manufacturing SMEs, conducting interviews and hosting interactive roundtables on the evolving manufacturing paradigm, and authoring thought leadership articles and blog posts via the Cell & Gene Collaborative blog.
Prior to launching Cell & Gene Collaborative, Anna Rose spent five years building an extensive network and editorial following as the Chief Editor of Biosimilar Development. In addition to penning thought leadership on biosimilar regulatory affairs, government policy, and commercialization advances, she was also an active participant in the biosimilar conferences circuit. She was appointed chair or served as a speaker and panel moderator at international conferences, including the World Biosimilar Congress USA, The Biotech Pharma Summit (EU), the CBI Biosimilars Summit, DIA Biosimilars Conference, and the Biosimilar Medicines Group Conference (EU). In 2018, she was invited to Brazil where she addressed members of the Brazilian Ministry of Health, ANVISA, and local biologics and biosimilar manufacturers on establishing national biologics and biosimilar policies. She also represented the publication on a media tour of Bangkok, Thailand in 2017, during which she reported on the country’s efforts to bolster its life sciences industry. In addition to writing for Biosimilar Development, she penned the introductory chapter to the book, Biosimilars: Regulatory, Clinical, and Biopharmaceutical Development (Springer, 2018).
In 2018, her first book of poetry, We, The Almighty Fires, was published by Alice James Books.
ARCHIVED ARTICLES
- ARW’s CGT+RNA Manufacturing Must-Reads (BAD PICKUP LINES EDITION!)
- From Capacity To Comparability: The Shifting Onus In Cell & Gene Therapy Outsourcing
- ARW’s CGT+RNA Manufacturing Must-Reads (GOOGLE SEARCH EDITION!)
- Sarepta’s FDA Adcom: Manufacturing Comparability In The Real World
- ARW’s CGT+RNA Manufacturing Must-Reads (COMPLAINTS EDITION!)
- FDA To Sarepta’s Gene Therapy: “Express Yourself…Maybe?”
- ARW’s CGT+RNA Manufacturing Must-Reads (Weird Contest Edition!)
- “Alice In [mRNA] Wonderland:” 3 Realities Facing The mRNA Industry
- ARW’s CGT+RNA Manufacturing Must-Reads (OUTLANDISH ‘HOLIDAY’ EDITION!)
- A Meditation On Change In The CGT Manufacturing Space